Differential roles for type I interferon and inflammatory pathways in autoimmune diabetes
Differential roles for type I interferon and inflammatory pathways in autoimmune diabetes
批准号:
10189495
负责人:
Jennifer P Wang
金额:
$59.24万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-06-30
关键词:
Anti-Inflammatory AgentsAntiviral AgentsAutoimmune DiabetesAutoimmune DiseasesAutomobile DrivingBeta CellCASP1 geneCRISPR/Cas technologyCandidate Disease GeneCellsCytokine SignalingDevelopmentDiabetes MellitusDoseGene ExpressionGene Expression ProfileGenesGoalsHumanHyperglycemiaIFNAR1 geneImmuneImmune responseImmune systemIncidenceIndividualInflammasomeInflammationInflammatoryInnate Immune ResponseInsulinInsulin-Dependent Diabetes MellitusInterferon ReceptorInterferon Type IInterferonsInterleukin-1Interleukin-1 ReceptorsInterventionIslet CellIslets of LangerhansIslets of Langerhans TransplantationKilham&aposs rat virusKnock-outLeadLinkLymphoid TissueMediatingModelingMonitorPancreasPathogenesisPathologicPathway interactionsPeripheral Blood Mononuclear CellPharmaceutical PreparationsPoly CPoly I-CPopulationPrevention strategyProcessRattusResearchRheumatoid ArthritisRiskRoleSalicylic AcidsSignal PathwaySignal TransductionSodium SalicylateSpleenStimulusStreptozocinStructure of beta Cell of isletSusceptibility GeneSystemic Lupus ErythematosusTestingTimeViralVirusVirus Diseasesanakinraautoimmune pathogenesiscytokinedesigndiabetes pathogenesisdiabetic ratdisorder preventioneuglycemiaexperimental studygenome editinghuman diseaseimmune activationinnate immune mechanismsinnate immune pathwaysinsulitisisletlead candidatelymph nodesmimeticspreventreceptorreceptor-mediated signalingrecruitresponsesingle-cell RNA sequencingtranscriptome sequencingtype I interferon receptorvirus development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Abstract
! Despite decades of intensive research, type 1 diabetes (T1D), which is characterized by autoimmune
destruction of the insulin-producing beta cells of the pancreas, still cannot be prevented. Understanding the
innate immunologic mechanisms for the development of T1D is crucial for developing preventive strategies.
Dissecting the interactions between environmental stimuli such as viral infection, immune responses, and the
development of insulitis (a key pathologic feature of T1D) in humans is extremely challenging. By temporally
defining such interactions in the rat model of autoimmune diabetes, we believe we can develop specific
interventions to target the human disease process.
We have found that the type I interferon (IFN) receptor (IFNAR), a key component of the innate immune
response to viral infection, is critically involved in development of virus-induced autoimmune diabetes in
weanling LEW.1WR1 rats. We will further define the role of type I IFN in the development of diabetes by
comparing immune cell recruitment between WT and IFNAR-/- rats and examining transcriptional profiles at the
single cell level. We will also determine if intrinsic IFN signaling in islets, including beta cells, contributes to the
development of T1D by performing islet transplants between WT and IFNAR-/- rats. Inflammatory pathways
also participate in the pathogenesis of autoimmune diabetes. We will determine if blockade of the interleukin-1
(IL-1) receptor will prevent type I IFN-independent diabetes. We will delineate mechanisms by which the anti-
inflammatory drug salicylate prevents diabetes. We plan to create a knockout rat using a CRISPR-Cas9 gene
editing strategy to examine the inflammatory pathway-mediated contribution to the development of
autoimmune diabetes.
Through the proposed studies, we will gain a fundamental understanding of immunologic responses
that lead to autoimmune diabetes. Notably, we will define both temporal aspects as well as key cell populations
involved in innate immune responses. Results from these experiments will reveal specific innate immune
pathways that participate in the development of insulitis and autoimmune diabetes and are essential for
developing preventive strategies for individuals who are at greatest risk for T1D.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Differential roles for type I interferon and inflammatory pathways in autoimmune diabetes
-
批准号:10431826
-
项目类别:
-
资助金额:$59.24万
-
财政年份:2018
-
负责人:Jennifer P Wang
-
依托单位:
Innate mechanisms for virus-induced diabetes
-
批准号:9522130
-
项目类别:
-
资助金额:$50.25万
-
财政年份:2016
-
负责人:Jennifer P Wang
-
依托单位:
Evaluation of the role of MDA5 in virus-mediated type I diabetes
-
批准号:8868007
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2011
-
负责人:Jennifer P Wang
-
依托单位:
Evaluation of the role of MDA5 in virus-mediated type I diabetes
-
批准号:8298127
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2011
-
负责人:Jennifer P Wang
-
依托单位:
Evaluation of the role of MDA5 in virus-mediated type I diabetes
-
批准号:8024745
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2011
-
负责人:Jennifer P Wang
-
依托单位:
Evaluation of the role of MDA5 in virus-mediated type I diabetes
-
批准号:8677682
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2011
-
负责人:Jennifer P Wang
-
依托单位:
Evaluation of the role of MDA5 in virus-mediated type I diabetes
-
批准号:8485536
-
项目类别:
-
资助金额:$38.66万
-
财政年份:2011
-
负责人:Jennifer P Wang
-
依托单位:
Macrophage defense againt M. tuberculosis
-
批准号:7028928
-
项目类别:
-
资助金额:$12.39万
-
财政年份:2004
-
负责人:Jennifer P Wang
-
依托单位:
Macrophage defense againt M. tuberculosis
-
批准号:6725294
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2004
-
负责人:Jennifer P Wang
-
依托单位:
Macrophage defense againt M. tuberculosis
-
批准号:7198023
-
项目类别:
-
资助金额:$12.39万
-
财政年份:2004
-
负责人:Jennifer P Wang
-
依托单位:
Macrophage defense againt M. tuberculosis
-
批准号:6898476
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2004
-
负责人:Jennifer P Wang
-
依托单位:
Macrophage defense againt M. tuberculosis
-
批准号:7418603
-
项目类别:
-
资助金额:$12.39万
-
财政年份:2004
-
负责人:Jennifer P Wang
-
依托单位:
海外基金